Deciphera Pharmaceuticals, Inc. Net Change in Cash
Deciphera Pharmaceuticals, Inc. reported Net Change in Cash of -$22.18 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-07.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2023-02-07
- Deciphera Pharmaceuticals, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2020-03-31 was $109.33M.
- Deciphera Pharmaceuticals, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2019-03-31 was -$211.54M.
- Deciphera Pharmaceuticals, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$22.18M.
- Deciphera Pharmaceuticals, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was -$49.09M, a 415.12% decline from fiscal 2020.
- Deciphera Pharmaceuticals, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was $15.58M.
- Deciphera Pharmaceuticals, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2019 was -$173.44M, a 278.79% decline from fiscal 2018.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$22.18M 10-K · filed 2023-02-07 | |||
| 2021-12-31 | -$49.09M 10-K · filed 2023-02-07 | |||
| 2020-12-31 | $15.58M 10-K · filed 2023-02-07 | |||
| 2020-09-30 | -$9.17M 10-Q · filed 2020-11-05 | |||
| 2020-06-30 | $35.13M 10-Q · filed 2020-08-04 | |||
| 2020-03-31 | $109.33M 10-Q · filed 2020-05-05 | |||
| 2019-12-31 | -$173.44M 10-K · filed 2022-02-08 | |||
| 2019-09-30 | -$120.05M 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | -$236.53M 10-Q · filed 2020-08-04 | |||
| 2019-03-31 | -$211.54M 10-Q · filed 2020-05-05 | |||
| 2018-12-31 | $97.01M 10-K · filed 2021-02-09 | |||
| 2018-09-30 | $124.12M 10-Q · filed 2019-11-04 | |||
| 2018-06-30 | $149.77M 10-Q · filed 2018-08-07 | |||
| 2017-12-31 | $139.29M 10-K · filed 2020-03-09 | |||
| 2017-09-30 | $24.69M 10-Q · filed 2018-11-08 | |||
| 2017-06-30 | $36.53M 10-Q · filed 2018-08-07 |